本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fortress Biotech Inc Series A P

17.64
-0.4700-2.60%
成交量:1.40萬
成交額:24.97萬
市值:6,045.40萬
市盈率:6.66
高:18.28
開:18.13
低:16.71
收:18.11
52周最高:21.43
52周最低:6.27
股本:342.71萬
流通股本:342.71萬
量比:3.01
換手率:0.41%
股息:- -
股息率:- -
每股收益(TTM):2.65
每股收益(LYR):-2.6890
淨資產收益率:-746.25%
總資產收益率:-32.37%
市淨率:2.72
市盈率(LYR):-6.56

資料載入中...

2020/05/26

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/19

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/05/11

重要事件披露

Current report, items 2.02 and 9.01
2020/05/11

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/04/28

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/23

重要事件披露

8-K - Current report
2020/03/16

重要事件披露

Current report, items 2.02 and 9.01
2020/03/16

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/02/12

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/01/27

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/12/31

重要事件披露

Current report, item 5.02
2019/11/26

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/11/26

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/22

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/12

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/12

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/12

重要事件披露

Current report, items 2.02 and 9.01
2019/11/12

季度報告

Quarterly report [Sections 13 or 15(d)]